#Diagnostic Labs Market

[nancykhemchandani]

Huda Market, sector 14, Faridabad faridabad Top-Rated Diagnostics

Looking for reliable and accurate medical testing services in Huda Market, sector 14, Faridabad faridabad? Look no further than our diagnostic centers.

[athenese-dx]

Celebrating 10 Years' Journey of Athenese-Dx Pvt. Ltd.

celebration #10years #athenesedx #Chennai #IVD #India #milestone

🎉 Celebrate a Decade of Innovation with Athenese-Dx! Join us in our 10th Anniversary Celebration as we continue to honor a decade of groundbreaking achievements at Athenese-Dx. This special video takes you on a journey through our most memorable moments, showcasing our commitment to excellence and innovation.

Highlights:

Milestone Moments: Relive our top achievements and how they've shaped the industry. From pioneering diagnostic technologies to life-changing breakthroughs, we've been at the forefront of medical advancements.Behind-the-Scenes: Get an exclusive look at the people and passion driving our success. Meet our brilliant scientists, dedicated researchers, and tireless support staff who have fueled our journey.Future Forward: Peek into the future as we unveil exciting plans for the next decade. Discover our vision for improving patient care, expanding global reach, and revolutionizing healthcare.

Thank You to Our Community: We extend our heartfelt gratitude to our customers, partners, and employees who have been part of our story. Your unwavering support and trust have propelled us forward.

Stay Connected: Don't miss out on any updates as we embark on the next chapter of our journey

diagnosticcenter #rapidtest #elisakit #biochemistry #ivdmanufacturing #clinicalchemistry #ivdinstrument #medicaldevices #reagents

Together, let's continue to redefine diagnostics and transform lives. Here's to the next ten years of excellence! 🥂 🎉 Cheers to many more amazing years! 🎉

ATHENESE-DX PRIVATE LIMITED Address: Module No. 407 & 408, 4th Floor, TICEL Bio Park II, No. 5, CSIR Road, Taramani, Chennai, Tamil Nadu - 600113, India

For Inquires - WhatsApp +917397238924 Click here to chat: https://wa.me/917397238924

For Reviews & News, go to https://www.athenesedx.com/

Follow us on WhatsApp Channel: https://whatsapp.com/channel/0029Va8M7HQChq6HfUBMLj0X

🌎 Visit our office - https://qr.page/g/5lZXERbP8Av

🤝 Subscribe - https://youtube.com/@athenesedx Our early diagnosis products for a better life. Thank you for your support.

🔔 For more videos, products, reviews ↷ YouTube ▶ https://youtube.com/@athenesedx

🌐 For more information ↷ Website ▶ https://athenesedx.com To Buy Athenese-Dx Products ▶ https://store.athenesedx.com

📱 Follow us on social media ↷ Facebook ▶ https://www.facebook.com/Athenese.Dx.Pvt.Ltd/ Instagram ▶ https://www.instagram.com/athenese_dx/ Pinterest ▶ https://www.pinterest.com/athenesedx/ X (Twitter) ▶ https://twitter.com/athenesedx Tumblr ▶ https://www.tumblr.com/athenese-dx LinkedIn ▶ https://www.linkedin.com/company/athenese-dx-private-limited/ Medium ▶ https://medium.com/@athenesedx01

[preetiken]

Philippines Pharmacy Retail Market is anticipated to grow by USD 6Th Mn by 2025- How will the market gain traction to be able to reach at its targeted number?

The government distribution of medicines will improve in future due to the initiatives such as Botika Ng Bayan, Distribution through Local Health Units and Rural Health Units, says a report by Ken Research

1.Corona Virus effect on pharmacy sales in Philippines Pharmacy Retail Market.

Other Challenges in Philippines Pharmacy Retail Market Outlook to 2025

Demand for OTC products like Alcohol Based Cleaners, Vitamin C and D Tablets, Immunity Boosters and Health Supplements was boosted during quarantine. Maintenance Medicines were also in high demand. During the starting of the Quarantine, Pharmacies witnessed increase in sales due to bulk purchase, later the sales declined. Pharmacies faced supply chain issues especially in the ECQ zones. This has affected the sales of the pharmacies. Further, Philippines witnessed lockdown for a long duration.

2.Trends and Development that the Pharmacy retail market of Philippines will experience.

Download Sample Report

In July 2018, DOH relaunched Botika Ng Bayan initiative to provide free essential medicines for common diseases focusing on rural and poor people. The chain stores have increased tremendously in the Philippines. Especially TGP and Generika as they have adopted franchise model for store expansion. This increase in chained pharmacies has led to the growth of house brands or private labels. In starting of 2019, President Rodrigo signed Universal Health Care (UHC) Bill into law (Republic Act No. 11223) which automatically enrolls all Filipino citizens in the National Health Insurance Program. This will increase the healthcare affordability in the region.

3. Assessing the Possibilities in the Philippines Pharmacy Retail Market

Ask For Customization

Penetration of internet, growth of social media has opened more connectivity options for the companies.

Drive Through Stores, self-service stores are increasing customer convenience.

This has helped in increasing the footfall in pharmacies for purchasing non pharmaceutical products.

Chain stores can serve regional customers where they don’t have strong presence.

Key Segments Covered

By Market Structure (In USD Billion)

Organized Market

Unorganized Market

Type of Store Location (In USD Billion)

Standalone Pharmacy

Hospital Based Pharmacy

By Region (In USD Billion)

North

Central

South

By Type of Sales (In USD Billion)

Prescribed Medicines

OTC Products

Non Pharmaceutical Products

Medical Equipment

By Type of Drug (In USD Billion)

Generic

Patented

By Therapeutic Class (In USD Million)

Cardiovascular

Anti-Infectives

Pain/Analgesics

Anti Diabetic

Vitamins/Minerals /Nutrients

Dermatology

Respiratory

Gastro Intestinal

Neuro

Oncology

Contraceptive

Gynecological

Ophthalmological

Others

Companies Covered

Mercury Drug Corporation

Watsons Personal Care Stores

SouthStar Drug Inc.

The Generics Pharmacy

Rose Pharmacy

Generika Drugstores

Several Regional Players & Others

Key Target Audience

Pharmaceutical Manufacturer Companies

Pharmaceutical Importing Companies

Pharmaceutical Distributing Companies

Major Retail Companies

E-Commerce Pharmaceutical Retailers

Consultancy Companies

Industry Associations

Regulation Bodies

Time Period Captured in the Report:

Historical Period: 2014-2019

Forecast Period: 2020-2025

Key Topics Covered in the Report

Healthcare System in the Philippines

Major Hospitals & Doctors in the Women Healthcare      

Usage of Contraception & Family Planning in the Philippines

Health Insurance in the Philippines

Supply Structure of the Philippines Pharmacy Retail Market

Trends & Development in the Philippines Pharmacy Retail Market

Issues & Challenges in the Philippines Pharmacy Retail Market

SWOT Analysis & BCG Matrix in the Philippines Pharmacy Retail Market

Philippines Pharmacy Retail Market Size & Segmentation, 2014-2019

Online Pharmacy Regulations in the Philippines

Telemedicine & Growth of Online Medical Consultation in the Philippines

Major Telemedicine Providers in the Philippines

Operating Model of Hybrid Pharmacies

Competition Scenario, Market Share, Cross Comparison of Major Players (Online & Offline) and Company Profile

Assessing Regional Pharmacies in the Philippines

Corona Virus Impact on the Consumer Behavior & Pharmacy Sales

Future Market Size and Segmentations, 2019-2025F

Covid 19 Impact on the Philippines Pharmacy Retail Market

Analysts’ Recommendations

Contact us:

Ankur Gupta, Head of Marketing and Communications

support@kenresearch.com

+91-9015378249

Follow Us

Facebook | Twitter | LinkedIn | Instagram

[covid-safer-hotties]

Do At-Home COVID-19 Tests Still Work? - Published Sept 6, 2024

These days, many people use at-home COVID-19 tests when they feel ill, rather than going out to get tested by a professional. (That’s when they bother to test at all.) But for all their convenience, the antigen tests commonly used at home have never been as accurate as PCR tests done in a lab—and the continued mutation of the virus raises additional concerns about their performance.

Rapid COVID-19 tests have never been perfect. How are they holding up as new variants emerge?

The U.S. Food and Drug Administration (FDA) continues to monitor the efficacy of the diagnostics it regulates—and as of August 2023, the FDA said none of the antigen tests on the market were expected to have reduced performance against Omicron or its subvariants. (All of the variants that have emerged since late 2021, including recent ones like KP.3.1.1, are relatives of the original Omicron strain.)

The FDA has also collaborated with a U.S. National Institutes of Health task force set up to monitor how variants affect tests. In 2022, well into Omicron's dominant era, that team concluded that DIY diagnostics continued to work well. Task force member Richard Creager wrote in an email to TIME that the tests still seem able to catch the Omicron spinoffs that are circulating now. “The rapid tests are having no issue detecting the variants,” he wrote, noting that the protein that antigen tests look for has remained fairly stable as the virus changes.

Even if tests have remained constant, our immune systems haven’t. Early in the pandemic, an infected person's “viral load”—the amount of virus in their system—tended to peak around the time their symptoms began. So if someone self-tested on the first or second day they felt sick, they likely had enough virus in their body for a rapid test to detect it.

Now that most everyone has prior immunity from multiple vaccines or infections, the timeline seems to be extended. Viral load now tends to peak around day four or five of symptoms, according to a study published in early 2024. That’s likely because the immune system is primed for action by its previous encounters with the virus, so it responds faster, even before lots of virus has built up in the body. A quicker immune response may mean a faster onset of symptoms.

“If your body has seen the virus before, you’re going to react to it and have an immune response more quickly,” explains study co-author Dr. Nira Pollock, co-director of the Infectious Diseases Diagnostic Laboratory at Boston Children’s Hospital. “That immune response can show up as symptoms.”

From an immune perspective, that’s a good thing. But it can complicate testing, because it means someone may not test positive for COVID-19 until they’ve already been feeling sick for days. In their recent study, Pollock and her co-authors estimated that a COVID-19 antigen test is somewhere between 30% and 60% accurate at detecting an infection on someone’s first day of symptoms, but up to 93% accurate on day four.

Based on such findings, Pollock and other researchers cautioned in a recent review article that people who are symptomatic shouldn’t assume they’re COVID-free based on a single negative antigen test result. Although it's a hard sell for people who no longer take precautions, the ideal scenario is for someone to stay isolated—or at least wear a mask when around other people—and test again around day four of symptoms.

“The instructions for these tests are to do serial testing,” Pollock says. “If you’re symptomatic, you should test early. But if you’re negative, you need to repeat it, because the amount of virus in your nose may not be high enough yet to detect.”

One other factor to consider: tests don’t last forever. Many people stockpiled tests when they were previously available for free through government programs and insurance, and those kits may have since expired. (You’ll soon be able to order four more free tests through the government.) The FDA’s website provides up-to-date guidance on determining how long your kits last.

Expired tests can still work, says Dr. Zishan Siddiqui, an assistant professor at the Johns Hopkins University School of Medicine. He co-authored a 2023 study on Abbott’s popular BinaxNOW tests, which found no major accuracy differences between unexpired tests and those that were five months past expiration. (Siddiqui’s other research suggests unexpired BinaxNOW tests accurately detect COVID-19 cases more than 80% of the time.)

But, although Siddiqui says he isn't too worried about using expired tests, it’s good to remember that their performance can suffer if they’re long past their recommended use dates. If the control line on your test strip doesn’t show up or looks distorted, that’s a good indication that it’s too old to use, he says. Even in Siddiqui's study, which found that expired tests still work, the lines on the old tests showed up more faintly than on fresh tests, making them harder to read.

Whether your tests are old or brand new, it’s good to use some healthy skepticism when interpreting their results. “I trust these tests,” even as the virus evolves, Siddiqui says—but a single result doesn’t always tell the whole story. If you have COVID-like symptoms but test negative, it’s best to be cautious and retest in a few days.

[mariacallous]

Chinese Hospitals Are Housing Another Deadly Outbreak

In Beijing and other megacities in China, hospitals are overflowing with children suffering pneumonia or similar severe ailments. However, the Chinese government claims that no new pathogen has been found and that the surge in chest infections is due simply to the usual winter coughs and colds, aggravated by the lifting of stringent COVID-19 restrictions in December 2022. The World Health Organization (WHO) has dutifully repeated this reassurance, as if it learned nothing from Beijing’s disastrous cover-up of the COVID-19 outbreak.

There is an element of truth in Beijing’s assertion, but it is only part of the story. The general acceptance that China is not covering up a novel pathogen this time appears reassuring. In fact, however, China could be incubating an even greater threat: the cultivation of antibiotic-resistant strains of a common, and potentially deadly, bacteria.

Fears of another novel respiratory pathogen emerging from China are understandable after the SARS and COVID-19 pandemics, both of which Beijing covered up. Concerns are amplified by Beijing’s ongoing obstruction of any independent investigation into the origins of SARS-CoV-2, the virus that causes COVID-19—whether it accidentally leaked from the Wuhan lab performing dangerous gain-of-function research or derived from the illegal trade in racoon dogs and other wildlife at the now-infamous Wuhan wet-market.

Four years ago, during the early weeks of the COVID-19 outbreak, Beijing failed to report the new virus and then denied airborne spread. At pains to maintain their fiction, Chinese authorities punished doctors who raised concerns and prohibited doctors from speaking even to Chinese colleagues, let alone international counterparts. Chinese medical statistics remain deeply unreliable; the country still claims that total COVID-19 deaths sit at just over 120,000, whereas independent estimates suggest the number may have been over 2 million in just the initial outbreak alone. Now, Chinese doctors are once again being silenced and not communicating with their counterparts abroad, which suggests another potentially dangerous cover-up may be underway.

We don’t know exactly what is happening, but we can offer some informed guesses.

The microbe causing the surge in hospitalization of children is Mycoplasma pneumoniae, which causes M. pneumoniae pneumonia, or MPP. First discovered in 1938, the microbe was believed for decades to be a virus because of its lack of a cell membrane and tiny size, although in fact it is an atypical bacterium. These unusual characteristics makes it invulnerable to most antibiotics (which typically work by destroying the cell membrane). The few attempts to make a vaccine in the 1970s failed, and low mortality has provided little incentive for renewed efforts. Although MPP surges are seen every few years around the world, the combination of low mortality and difficult diagnostics has meant there is no routine surveillance.

Although MPP is the most common cause of community-acquired pneumonia in school children and teenagers, pediatricians such as myself refer to it as “walking pneumonia” because symptoms are relatively mild. Respiratory Syncytial Virus (RSV), influenza, adenoviruses, and rhinoviruses (also known as the common cold) all cause severe inflammation of the lungs and are far more common causes of emergency-room visits, hospitalization, and death in infants and young children. Why should MPP be acting differently now?

One contributing factor to the severity of this outbreak may be “immunity debt.” Around the globe, COVID-19 lockdowns and other non-pharmaceutical measures meant that children were less exposed to the usual range of pathogens, including MPP, for several years. Many countries have since seen rebound surges in RSV. Several experts agree with Beijing’s explanation that the combination of winter’s arrival, the end of COVID-19 restrictions, and a lack of prior immunity in children are likely behind the surging infections. Some even speculate that that substantial lockdown may have particularly compromised young children’s immunity, because exposure to germs in infancy is essential for immune systems to develop.

In China, MPP infections began in early summer and accelerated. By mid-October, the National Health Commission had taken the unusual step of adding MPP to its surveillance system. That was just after Golden Week, the biggest tourism week in China.

Infection by two diseases at the same time can make things worse. The usual candidates for coinfection in children—RSV and flu—have not previously caused comparable surges in pneumonia. One difference this time is COVID-19. It is possible that the combination of COVID-19 and MPP is particularly dangerous. Although adults are less susceptible to MPP due to years of exposure, adults hospitalized for COVID-19 who were simultaneously or recently coinfected by MPP had a significantly higher mortality rate, according to a 2020 study.

Infants and toddlers are immunologically naive to MPP, and unlike COVID-19, RSV, and influenza, there is no vaccine against MPP. It seems implausible that no child (or adult) has died from MPP, yet China has not released any data on mortality, or on extrapulmonary complications such as meningitis.

Most disturbing, and a fact being downplayed by Beijing, is that M. pneumoniae in China has mutated to a strain resistant to macrolides, the only class of antibiotics that are safe for children less than eight years of age. Beyond discouraging parents to start ad hoc treatment with azithromycin, the most common macrolide and the usual first-line antibiotic for MPP, Beijing has barely mentioned this fact. Even more worrying is that WHO has assessed the risk of the current outbreak as low on the basis that MPP is readily treated with antibiotics. Broader azithromycin resistance in MPP is common across the world, and China’s resistant strain rates in particular are exceptionally high. Beijing’s Centers for Disease Control and Prevention reported macrolide resistance rates for MPP in the Beijing population between 90 and 98.4 percent from 2009 to 2012. This means there is no treatment for MPP in children under age eight.

Fears over a novel pathogen are already abating. After all, MPP is rarely lethal. But antimicrobial resistance (AMR) is. Responsible for 1.3 million deaths a year, AMR kills more people than COVID-19. No country is immune to this growing threat. Since China, where antibiotics are regularly available over the counter, leads the world in AMR, it is inconceivable that this issue hasn’t yet come up, particularly during WHO’s World AMR Awareness week, from Nov. 18 to Nov. 24.

Any infectious disease physician would want to know: Did WHO asked China the obvious question—what is the level of azithromycin resistance of M. pneumonia in the current outbreak—and include the answer in its risk assessment? Or did it ask about resistance to doxycycline and quinolones, antibiotics that can be used to treat MPP in adults? Even if WHO did ask, China isn’t telling, and WHO isn’t talking.

China’s silence isn’t surprising. Its antibiotic consumption per person is ten times that of the United States, and policies for AMR stewardship are predominantly cosmetic. While surveillance is China’s strong point, reporting is not.

Despite Spring Festival, the Chinese celebration of the Lunar New Year and another peak travel period, approaching in February 2024, WHO hasn’t advised any travel restrictions. It should have learned the danger of accepting Beijing’s statements at face value. Four years ago, Beijing’s delay enabled more than 200 million people to travel from and through Wuhan for Spring Festival. That helped COVID-19 go global. Since China’s AMR rates are already so high, importing AMR from other countries isn’t a major concern for China. Export is the issue, and China’s track record in protecting other countries is abysmal.

Rather than repeating the self-serving whitewashing coming from Beijing, WHO should be publicly pressing China about the threat of mutant microbes. Halting AMR is essential. Before antisepsis and antibiotics, surgery was a treatment of last resort. Without antibiotics, we lose 150 years of clinical and surgical advances. Within ten years, we are at risk of few antibiotics being effective. It may not be the novel virus that people were expecting, but the next pandemic is already here.

[whitherwanderer]

17 // diagnostic (extra credit)

Welcome to SelfMed, your online personal medical evaluation assistant! If this is a medical emergency, please contact local authorities or Trauma Team for immediate help.

How can SelfMed assist you today?

>> diagnosis

Please list up to five major symptoms for a diagnosis using our QuickMatch™ technology.

[1] fever [2] headache [3] mania [4] hallucinations [5] not recognizing faces

———

QuickMatch™ Potential Diagnoses*

The symptoms listed are a complete or partial match to the diseases and disorders below:

Click for more information and recommended treatment options.

Schizophrenia [+]

Post-Traumatic Stress Disorder (PTSD) [+]

Cyberpsychosis [–]

Cyberpsychosis is a collective term for all psychotic and anxiety-related personality disorders caused by hardware implanted in the body and any and all behavioral mods, including software. Often this begins as changes to the personality, followed by increasingly erratic and even violent behavior. Some medications and substance abuse can worsen these behaviors. Recommended treatment options: - Therapy - Implant deactivation and/or removal - Bethaloperidol While antipsychotics are widely used to slow the onset of cyberpsychosis, therapy has also proven effective for some patients after years of treatment. Those experiencing aggressive cyberpsychotic symptoms such as violent outbursts should be kept away from public spaces and denied access to weapons until they can be incapacitated, restrained, and removed for treatment. If you or someone you know is experiencing symptoms of cyberpsychosis that result in erratic or violent behavior, remove yourself from any potentially dangerous situations and call MaxTac. Do NOT interrupt MaxTac officers during an ongoing violent situation. DO put as many walls between the situation and yourself as is possible to avoid stray projectiles and bodily harm.

*QuickMatch™ diagnoses are a quick-screening technology and should not be used to replace the services of a trained medical professional.

———

Your free trial SelfMed membership is valid for the next [7 DAYS]. 

By upgrading to a premium membership, you can access an additional seven diagnoses. Would you like to upgrade to a SelfMed premium membership today? (€$199 per mo.)

Enter promo code HEALTH10NOW for a limited time offer of 10% your first month of premium service!

———

Is there something else SelfMed can assist with?

>> nethaloperidol

We’re sorry, but we didn’t recognize that prompt.

Is there something else SelfMed can assist with?

>> bethaloperidol

Searching “bethaloperidol” yielded the following articles:

Bethaloperidol [–]

Bethaloperidol is an antipsychotic used to treat a broad range of disorders, ranging from Schizophrenia to hyperactivity. When prescribed by a doctor in combination with therapy, bethaloperidol has been proven effective in helping patients recover. Bethaloperidol can be taken in pill form or through injection. The most widely used brands are Bethal and Novadol. Though black market bethaloperidol is frequently sold, it is not created in a lab environment where product quality is overseen, it is likely a cheaper alternative that will not address symptoms adequately, and/or it has been cut with other drugs that could be a potentially dangerous cocktail. Brand names are always recommended and more effective than their black market counterparts.

———

Searching for the nearest retailer that carries BETHALOPERIDOL? We’ve found 10 locations near you, less than 5 minutes away!

Upgrade to a premium membership to find trusted pharmaceutical outlets near you. (€$199 per mo.)

Enter promo code HEALTH10NOW for a limited time offer of 10% your first month of premium service!

———

Is there something else SelfMed can assist with?

>> ripperdoc

Searching “ripperdoc” yielded the following articles:

Ripperdocs: the new GP or back alley surgeon? [+]

Top 10 most horrifying ripperdoc patient stories [+]

Confessions of a street doctor: ripper reveals all [+]

Is there something else SelfMed can assist with?

>> nearest ripperdoc

We’re sorry, but we didn’t recognize that prompt.

Is there something else SelfMed can assist with?

>> fuck off

———

Thank you for using SelfMed!

Your feedback matters! Please rate your experience.

☆☆☆☆☆

[rokhal]

With my car in the shop INDEFINITELY (needs a new emissions control part that is constantly back-ordered because the current one blows a fuse that powers the computer that controls the engine) I got the chance to talk to a Real Living Breathing Mechanic.

Apparently, continuing education trips are a Thing for automotive technicians. Not the guys who change your tires and your oil, but the guys who diagnose your engine problems. There's apparently like conventions the shop will fly people to so they can get training. They have classes and modules and workshops and stuff year-round.

I'm thinking, a shop like Canelo's which mainly does classics probably doesn't see much call for that kind of thing, but with Priuses and Leafs etc growing more plentiful in the used market, and more complex modern conventional cars also getting worn down and dropping in value, Canelo might just bite the bullet and send his best two diagnostic techs for a week of lecture and labs or whatever car people call their surgical training.

So Robbie and Ramón Cordova have to go to Kansas and survive on whatever pitiful stipend Canelo provides without attacking each-other.

[moonjxsung]

ALSKDKDJF OKAYYY !!! I’m glad it’s not a bother !!! I overthink sometimes alskdkjf

urgh so I am having A WEEK :( I hope it’s okay I rant a bit … alslkskdj

helurf okay so after midterms last week, I’ve been trying to like relax and give myself time to rest but IVE HAD SO MANY ASSIGNMENTS :((( and I’m so tired and burnt out and stressed cause I need to start studying for finals and ahhhhhh alsksjjdjf :(

okay now for some more fun updates!! i had fun at uni yesterday!! we had a super fun soil science lab we got to go into soil pits on the farm our campus has and analyze soil (ph, diagnostic horizons, colour, structure, texture etc) !! It was a lot of fun I’m gonna miss the class and my prof :( (it was my last lab)

another fun thing is its art market week at my uni so time to drop a ton of money on prints, stickers and crocheted animals !!! :D

AND okay so I made it into a special like abroad research kinda program/course in like that’s usually only available to upper years students but somehow I made it in alskkskdjdj . Anyways, we get to go to South Africa from like May 14-June 9 to do research and stuff in the field!!! and like IM SO EXCITED??? So anyways, the 19 students that also made it in (it’s a highly competitive program to get into) we had our second group meet up plus our prof (who taught my favourite class by far last term) yesterday and it was a lot of fun and we got free dinner which was super super yum and I can’t believe I’m actually going ahhhhh

and then I went to a friends house for dinner (yes, dinner again) which was fun we like catch up at least once a month and yeah

Anyways sorry for the truck load of information about my life weh

HOW IS YOUR LIFE STAR!!! I WANNA HEAR ABOUT YOU!! (With whatever ur feeling comfy sharing 💗)

🌱

UGH I always forget how close together exam season is WHYYYY ARE UR FINALS ALREADY RIGHT AROUND THE CORNER….. 💔💔 I believe in you angel manifesting all the best for you frfr you’re smart I know you got this 🫶🫶🫶🫶

AHHHH UR UNI LAB SOUNDED SO FUN I love labs where you just get to go outside and do stuff in nature it’s fr so healing 👼 I took a geology course in college where we got to go to this creek near my school and like test the ph balance of the water and it was so much fun being outside instead of cooped up in the lecture hall fr one of the best labs we ever did. AND the art market this week???? RAHHH HAVE SO MUCH FUN we used to have something similar at my uni and I would drop SO much on stickers not even joking my laptop is covered in them still :’)

ALSO OH MY GOD??? TO THE STUDY ABROAD PROGRAM?????? STOP THAT SOUNDS SO FIXKIFNT FUNNNNN IM SO EXCITED FOR YOU WYAHWJDNRJ CONGRATS ON GETTING IN BB ‼️‼️ I didn’t have to do study abroad when I was in college bc covid hit but I can’t wait to hear all about yours and live vicariously thru ur updates AHHHH and it’s coming up so soon !! WOWOWOWOW HAVE THE BEST TIME ILY ILY THATS SO FUN

My day was honestly vvvvv boring but it was productive! I had work and then I had a shit ton of laundry to do but I was tired as fuck and I have cramps bc my period started today so I got coffee first to wake me up and then after cleaning the apartment I caught up on Ateez vlogs and now I’m simultaneously writing and watching Zelda gameplay 👼 I think my emotions are like ten times worse rn because of my period so I’m just taking it easy but I have a huge party to go to this weekend and a lot of my friends are gonna be there so I need to get my shit together and stop being sad bc I don’t want to bring the mood down ☹️ why do I always have a party in the same week I feel like shit LOL the last time I had one my situationship and I got into a huge fight and my sister had to be checking on me like every 5 minutes bc I was borderline crying the whole night it was so embarrassing 😭 (I am so tired of crying over this same girl oh my god)

ANYWAYS I LOVE U ANGEL IM SO HAPPY FOR YOU AND I CANT WAIT TO HEAR ALL ABOUT UR STUDY ABROAD TRIP RAHHH THATS SO EXCITING CONGRATS AGAIN ILY ILY 🩷💖💞💘💕💓👼

[nancypullen]

MIA

Yep, I've let too many days pass without posting. I've missed the opportunity to crow about how much fun Halloween was, we're already more than a week into November! We did have a grand time though. Trick-or-treating with our little miss in her fun neighborhood ticks all of the boxes on my perfect Halloween check list. I popped on my witch hat and my sweatshirt and had as much fun as the kids.

I'm trying to be better about sharing pictures of myself (ugh!) so that when I'm dead my kids can have something to prove I was here.

Yes indeed, we gave October a fantastic send off and November arrived with chillier weather and even more color in the trees. Absolutely beautiful.

I've been busy filling a big earring order, and keeping appointments. My in-person interview at the library went well ( I thought) but I haven't heard a peep. I can't worry about that. I know I'm qualified and would be helpful and cheerful to the patrons, but I still may not be what they're looking for - who knows? If not there, I'll find something else. I had a follow up appointment after my yearly physical/ lab work because my blood pressure was up. That's really unusual for me, so I had to track it for a month and then bring my monitor in and all that. Turns out I'm normal, I just don't like going to the doctor. I'm really glad that I don't have to take meds. I'm too forgetful for that.

Then, I received a call that my mammogram results were abnormal and showed a "developing asymmetry" in the left breast. Tomorrow I have to go to Easton for a diagnostic mammogram and an ultrasound. I'm 99% sure that it's nothing, probably just normal changes, but for someone who doesn't like going to doctors and/or having procedures, enough already! If this is what getting older is like, I'm not a fan. I told a friend that it's probably a lump of cookie dough that didn't make it all the way to my hips - much ado about nothing.

When I'm not kneading clay and baking earrings, or getting poked and prodded by medical personnel, I'm trying to prepare for the upcoming holidays. I love an October vacation, and Ireland was sublime, but it tends to dump me right at the doorstep of Thanksgiving and Christmas and I'm not ready for either one! I confess to playing some Christmas tunes already, just to get in the mood. I feel like I'm way behind. I've been trying to come up with our card for this year and the creative well is running dry. They just get thrown away by the recipients, why not just pick up a couple boxes of cards at Target? That would be smarter and I could cross it off my list. I know that I'm one of the dinosaurs still sending out holiday cards, but I love getting them in my mailbox and one must give in order to receive, right? So that's my quick check in, and my apology for being tardy with this post. Tomorrow I'll ship those earrings off to Florida and go get my boob smashed again, and then my schedule will be nothing but holiday madness. I'm looking forward to it. It's time to get my jingle on!

The Edgewater gang will come over this weekend and I'll have to make sure that I have a grasp on the grandgirl's list for Santa. I have a toy catalog here that should inspire her. Everyone else is getting socks and a toothbrush. Just kidding, but that sure would be easy. When am I old enough to start doing that? They'll head to Tennessee for Thanksgiving, but will be with us for Christmas. Matt is flying in for Thanksgiving, then in December he jets off to Brugge, Belgium and Amsterdam for the Christmas markets. He'll be here for Christmas week full of stories to share. I can't wait. On that happy note, I'll head of to soak in a bubble bath and then snuggle under the covers with a book. I'm pooped. Until tomorrow, stay safe, stay well...and

You better watch out You better not cry You better not pout I'm telling you why

… Santa Claus is comin' to town! 47 days!!! XOXO, Nancy

[homehealthcarehub101]

Home PCR Tests: A Closer Look at the PCR Test At Home Dubai Option

The COVID-19 pandemic sparked major growth in the development and usage of diagnostic and antibody tests that patients can self-administer from home. Home PCR tests in particular enable private, convenient detection of active coronavirus infections. For those wondering whether accurate PCR Test At Home Dubai kits are available, exploring the leading options provides helpful guidance.

How Do Home PCR Tests for COVID-19 Work?

The PCR (polymerase chain reaction) technique is the gold standard for directly detecting the presence of the COVID-19 virus from respiratory samples. Home PCR test kits allow patients to collect their own nasal or saliva samples and perform the PCR assay without visiting a clinic.

PCR tests work by identifying the specific genetic material of the COVID-19 virus. Users collect a sample, mix it with chemical reagents, and insert the solution into the test kit for analysis. Results are displayed indicating whether viral genetic material was detected based on any color change reaction on the test strips.

Kits include step-by-step instructions to ensure patients perform the easy, quick tests properly using non-invasive nasal swabs or saliva collection. Many provide results within 10-30 minutes.

Here is a video from MedCram Youtube Channel about At Home Rapid COVID 19 Tests and False Positives (Coronavirus Antigen Tests). Watch the video

Benefits of At-Home PCR Testing

Here are some of the major advantages of having access to accurate home PCR tests for COVID-19:

Convenience: Test from the privacy of your residence without traveling to clinics.

Speed: Get results rapidly within minutes rather than waiting days for lab tests.

Self-Administered: Users can collect their own sample comfortably rather than relying on technicians.

Affordability: Individual kits are very competitively priced.

Detection Reliability: PCR technology directly identifies viral presence with high accuracy.

Ease of Use: Tests have simple, straightforward instructions for patients of all ages.

Infection Verification: Confirms active infections unlike antibody tests.

Having the option to privately, quickly, and accurately test for possible COVID-19 infections at home provides significant peace of mind during the pandemic.

How Reliable Are Home PCR Tests?

Many people reasonably wonder whether DIY home PCR test kits can match the reliability of lab-based PCR tests. The good news is that leading home PCR kits on the market have very high accuracy.

Most kits have published sensitivity and specificity above 90% when compared to lab PCR tests. High quality home tests analyze samples using comparable PCR methodology and match labs in detecting positives and negatives.

Furthermore, unlike Rapid PCR Test At Home kits some vendors offer, full home PCR tests analyze the sample through many amplification cycles to maximize accuracy. With good sampling collection, top home PCR kits offer laboratory-grade results conveniently at home.

Leading Home PCR Test Kit Options

For those exploring PCR Test At Home Dubai choices, here are some of the top-rated home PCR kits to consider:

Cue Health PCR Test: Cue offers an FDA-authorized home PCR test delivering highly accurate results in 20 minutes with nasal swab samples.

Lucira Check It PCR Test: This is a single-use PCR kit with 98% validated accuracy that provides molecular-level detection from nasal samples in 30 minutes or less.

Ellume COVID-19 Home Test: This over-the-counter home kit uses a mid-turbinate nasal sample and provides an amplified PCR digital reading of positive or negative in 15 minutes on a connected analyzer.

Pixel by LabCorp PCR Test: Pixel is a monitored at-home nasal PCR test analyzed through LabCorp with over 98% accuracy returning results within 1-2 days.

Doximity's Covid-19 PCR Test: Doximity partners with qualified labs for monitored video-observed PCR testing with 97%+ accuracy and results in 24 hours.

All these options allow for convenient, accurate at-home COVID-19 testing using PCR with trusted partners. Kits can be purchased online and shipped directly to your home in Dubai.

When Are Home PCR Tests Recommended?

The CDC recommends utilizing home PCR tests in situations such as:

If you have any symptoms of COVID-19. Home testing allows quick confirmation.

After exposure events to quickly check for possible infection.

Before visiting individuals at higher risk for severe illness.

Before travel or group events for added assurance.

For frequent screening in schools or workplaces.

Even fully vaccinated individuals should test if they experience COVID-like symptoms or have a known exposure. Home PCR tests make quick detection fast and easy.

Home PCR Tests Offer Accuracy and Convenience

High quality Home PCR Tests have become an important tool in the fight against COVID by making reliable diagnostic testing accessible outside of clinics. There are excellent PCR Test At Home Dubai options available matching the standards of lab PCR sensitivity and specificity. Home PCR kits allow people to conveniently and confidently check themselves for possible COVID-19 infections from the privacy of home. As the technology continues advancing, home collection PCR will likely take on an increasingly vital role supporting public health and safety.

[transorzevarsha1]

Best Medical Coding Institute in Nagercoil

MEDICAL CODING

Medical coding is the process of extracting data from a doctor's notes on a patient's medical history, including medical procedures, diagnoses, necessary medical equipment, and medical services. This data is converted into standard medical alphanumeric codes by a medical coder.

There are three types of universally known medical alphanumeric codes:

The World Health Organization (WHO) developed the International Classification of Diseases (ICD), a system that is widely utilised. The classification system is primarily used for data collecting and health records, among other things. These codes can categorise signs, conditions, illnesses, and fatalities. 

CPT codes are used in the US to identify certain medical, surgical, and diagnostic operations and services. This system, which has three categories—procedures and modern medical practises, clinical labs, and developing technologies—was created by the American Medical Association (AMA). 

The Centers for Medicare and Medicaid Services (CMS) created the Healthcare Common Procedure Coding System (HCPCS) to facilitate in the processing of insurance claims for Medicare or other providers. They are used by coders to record medical processes, goods, services, and merchandise.

Transorze is an ISO 9001:2015 certified company for delivering high quality “Healthcare BPO” training and placement services, totally dedicated in providing the services of Medical Transcription Training,Medical Coding Training , Medical Scribing Training, ,Digital Marketing Training.

Contact details

Phone no: +919495833319

E Mail:tips.ashif@gmail.com

[kenresearchcompany]

Thailand Clinical Laboratory Industry Has Evolved Over the Years and Has Become a Critical Solution Provider: Ken Research

Buy Now

Expanding healthcare spending by the Government, increasing healthcare spending by aging population and increasing public awareness led to the growth of the Clinical Laboratory Market in Thailand.

Thailand Clinical Laboratory Market Overview: The Clinical Laboratory Market in Thailand is currently at the growth stage and is a consolidated market. The market has been driven by growth in non-communicable disease and chronic diseases, increasing focus on preventive medicine, ageing population, increase in awareness levels, rising disposable income and preference for evidence based treatment. The Thailand Clinical Laboratory Market grew from 6.7% in 2017 to 12.3% in 2021 in terms of revenue generated, due to the growing demand for clinical laboratory services in the country.

Challenges Faced by Thailand Clinical Laboratory Market: In spite of the growing demand for diagnostic services, affordability remains a concern. Budget constraints from both public and private payers are pushing costs lower. The number of sample sales and test price are very competitive among both organized and unorganized businesses. Diagnostics facilities need to modify their technology frequently to maintain a competitive edge. However, these improvements not only require large construction expenditures but also raise maintenance expenses. This is essential, especially for smaller players with little resources. Lack of laboratory accountability for the services that they render, insufficient oversight of suppliers, consumables, supplies, and laboratory equipment in terms of price, commitments, and warranty support; are still very challenging issues.

Supportive Government Initiatives: Thailand’s reform places a heavy emphasis on improving a district health system that is pro-rural and pro-poor. To promote lab accreditation and restore consumer trust, the government has established national accreditation bodies such as the Thailand Laboratory Accreditation Program. The national accreditation program was established as a local alternative to make it affordable, feasible, scalable, sustainable, and effective. In 2008, Thailand’s Universal Coverage Scheme (UCS) was extended to include wider coverage. The UCS plan focuses on minorities and the poor and near-poor, with the aim of offering the most comprehensive coverage possible. It includes extensive outpatient and inpatient health care, as well as prevention and health promotion, in addition to basic hospital fees.

Analysts at Ken Research in their latest publication “Thailand Clinical Laboratory Market Outlook to 2026F- Driven by current shortage, widening customer base, Government initiatives and increasing corporate requirements for clinical testing” by Ken Research observed that Thailand Clinical Laboratory Market is in the growing phase. Increasing healthcare spending by aging population, expanding healthcare spending by the Government and increasing public awareness are some of the factors that will contribute to the Thailand Clinical Laboratory Market growth over the period of 2022F-2026F. It is expected that Thailand Clinical Laboratory Market will grow at a CAGR of 9.5% for the above forecasted period.

Key Segments Covered

Thailand Clinical Laboratory Market:

By Independent Laboratory

Organized Labs

Unorganized Labs

By Payer

Private Health Insurance

Corporates

Out of Pocket

By Customers

Walk-Ins

Doctor Referrals

Corporate Clients

Online Bookings

Request for a Free Sample Report @ https://www.kenresearch.com/sample-report.php?Frmdetails=NTk2MjIz

By Type of Tests

Routine

Esoteric

Non-Laboratory

By Type of Routine Tests

CBC (Complete Blood Count)

A1C

Basic Metabolic Panel

Others

By Type of Esoteric Tests

Infectious Disease

Endocrine

Allergic Disease

Oncology

Others

By Region

Bangkok

Nakhon Ratchasima

Samut Prakan

Ubon Ratchathani

Khon Kaen

Others

By Type of Laboratory in Private Hospitals

In-house Labs

Third Party Tie-Ups

Key Target Audience

Clinical Laboratory companies

Organized Clinical Laboratories

Unorganized Clinical Laboratories

Private Hospitals

Private Equity and Venture Capitalist

Industry Associations

Technology providers

Government Bodies & Regulating Authorities

Time Period Captured in the Report:

Historical Period: 2016-2021

Base Year: 2021

Forecast Period: 2022F– 2026F

Companies Covered:

Organized Labs

N Health

Pathlab

Thonburi Clinical Labs

Bangkok Medical Labs

BRIA Group

MIC Labs

Unorganized Labs

Medical Line Lab

Innotech Laboratories

Service Co., Ltd.Innolab

Prolab 

Pattaya Clinic Laboratory

CCS Medical laboratory

Excellent Pathological

Lab Company Limited

DNA Testing Laboratory Co.,Ltd.

Pathology Diagnostic Center

Ubon Pathology

Rachvipa MRI Company Limited

hi-tech lab

Bangkok Pathology-Lab

Inter-Lab Pathology and Research Center

Key Topics Covered in the Report

Thailand Clinical Laboratory Market Overview

Thailand Healthcare Overview

Ecosystem of Thailand Clinical Laboratory Market

Thailand Clinical Laboratory Market Segmentation

Industry Analysis of Thailand Clinical Laboratory Market

Value Chain of Clinical Laboratory Market in Thailand

Key Growth Drivers in Thailand Clinical Laboratory Market

End User Analysis of Thailand Clinical Laboratory Market

Key Challenges of Thailand Clinical Laboratory Market

SWOT Analysis of Thailand Clinical Laboratory Industry

Future Outlook of Thailand Clinical Laboratory Industry

Trends and Development of Thailand Clinical Lab Market

COVID-19 Impact on Clinical Laboratory Market in Thailand

For more information on the research report, refer to below link:

Thailand Clinical Laboratory Market Outlook to 2026F

Related Reports

Philippines Clinical Laboratory Market Outlook to 2027F

Indonesia Clinical Laboratory Market Outlook to 2026F (Second Edition)

Vietnam Clinical Laboratory Market Outlook to 2022 

[rohit890]

Clinical Trial Imaging Market 5.9% CAGR Projection Over The Next Five Years

Market Overview

Clinical Trial Imaging is the use of imaging modalities, analysis services, and software to ascertain the effectiveness of innovative drugs before they are made available for purchase. Clinical imaging methods are being utilised more frequently in oncology treatment trials to demonstrate the efficacy and safety of the drug. Positron Emission Tomography (PET), Optical Coherence Tomography (OCT), Magnetic Resonance Imaging (MRI), and Ultrasound are the imaging technologies most frequently employed in clinical trials. During the projection period, the market is anticipated to be driven by the rise in cancer diagnoses and deaths globally. However, it is anticipated that the industry's growth prospects will be constrained by the severe government regulations in the field.

View Detailed Report Description: https://www.globalinsightservices.com/reports/clinical-trial-imaging-market/

Market Dynamics

The most important aspect, like an increase in R&D expenditures, is an increase in R&D expenditures. Companies in the pharmaceutical and biotechnology industries spend a lot of money on research to create novel compounds. The market for clinical trial imaging is predicted to grow as a result of rising government and pharmaceutical R&D spending as well as a growing emphasis on life science projects to create new therapeutic and diagnostic products. Similarly, developing nations like India, South Korea, Brazil, and Mexico present substantial potential opportunities to market participants in clinical trial imaging, primarily as a result of the rising R&D investment in these nations.

A notable trend in these emerging markets is the commercialization of life science research. These economies are expected to present the clinical trial imaging market with substantial growth prospects due to considerable advancements in life sciences research. Additionally, there are other CROs that provide drug development services to pharmaceutical and biotechnology businesses in Asian markets, particularly China and India. The need for clinical trial imaging is predicted to rise in emerging nations in the next years due to the large increase in R&D spending and CROs operating in these nations.

The key players in the global clinical trial imaging market are ICON plc. (Ireland), BioTelemetry Inc. (US), Biomedical Systems Corporation (US), Medpace Holdings, Inc. (US), IXICO plc. (UK), Resonance Health Ltd. (Australia), Radiant Sage LLC. (US), BioClinica Inc. (US), Intrinsic Imaging LLC. (US), Cardiovascular Imaging Technologies LLC. (US), Medical Metrics Inc. (US), Prism Clinical Imaging, Inc. (US), Boston Imaging Core Lab LLC. (US), anagram 4 clinical trials (Spain), Lyscaut Medical Imaging Company (Belgium), Calyx Group (UK), Bioseptive Inc. (Canada), ProScan Imaging LLC. (US), Micron Inc. (Japan), Imaging Endpoints LI, LLC (US), Perspectum Ltd. (UK), Pharmtrace Klinische Entwicklung GmbH (Germany), WorldCare Clinical, LLC (US).

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: info@globalinsightservices.com

Phone: +1–833–761–1700

[tamanna31]

Clinical Trial Imaging 2023 Industry Report Potential Growth, Share, Demand And Forecast to 2030

Clinical Trial Imaging Industry Overview

The global clinical trial imaging market size was estimated at USD 1.14 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.60% from 2024 to 2030. The market growth is anticipated to be fueled by the growing biotechnology and pharmaceutical sectors, coupled with rising investments in research and development for the creation of new drugs aimed at treating various diseases. Medical imaging plays a pivotal role in advancing the development of innovative life science products.

Gather more insights about the market drivers, restrains and growth of the Clinical Trial Imaging Market

Despite the ever-changing nature of the medical imaging industry, the biotechnology and pharmaceutical industries are showing sustained growth. This is primarily due to the increased investment in medical imaging companies, as well as the occurrence of mergers and acquisitions that involve the incorporation of cutting-edge imaging technologies to facilitate clinical trials for medical devices.

Advancements in technology are bringing substantial improvements to the collection, evaluation, and submission of clinical trial imaging data. Technology-enabled imaging, especially image analysis software, provides various benefits to clinical studies, such as consistency, data accuracy, adaptability, and compliance. For instance, image analysis software is used to direct and manage a reader by analyzing imaging time points. In addition, the increased use of imaging technology, along with the enhanced power of computing, is expected to drive the usage of imaging in clinical trials. The Quantitative Imaging Biomarkers Alliance (QIBA) protocol has come up with standardized methods and imaging procedures with uniform procedures to be implemented for attaining statistical and precise endpoints in clinical trials.

The Covid-19 pandemic has adversely impacted the healthcare system in most countries, leading to a disruption in medical studies, and research activities, and reduced sponsorship for research involving clinical trials. The pandemic hampered the clinical trial timeline as numerous ongoing studies were delayed and planned studies were cancelled. Unfavorable changes in regulations and guidelines, supply chain disruption, recruitment challenges for clinical trials, fear of viral spread, and shutting down of most manufacturers during lockdown have adversely impacted the market. However, introducing virtual imaging trials during the COVID-19 pandemic is expected to open new avenues for adopting these devices. The development of advanced computational models helps better assess CT and radiography images, which are expected to help in the early diagnosis of COVID-19 patients. The market has witnessed a bounce back by 2022 Q2 due to increased R&D activities and improvement in supply and distribution channels.

Many patents have been filed in the realm of enhancing image evaluation and capturing. In addition, imaging core lab provider’s offer patented technologies that are anticipated to assist pharmaceutical companies in reducing their development timelines. As an example, IXICO provides a diagnostic tool called Assessa, which enhances decision-making in clinical trials for conditions related to memory, including schizophrenia, Parkinson's, and Alzheimer's disease, as well as neurological disorders such as dementia and cognitive impairment. However, the high cost of machinery and their installation, and the enormous cost of clinical trials may limit the market growth during the forecast periods. Advancements in technology are bringing substantial improvements to the collection, evaluation, and submit clinical trial imaging data. Technology-enabled imaging especially image analysis software provides various benefits to clinical studies such as consistency, data accuracy, adaptability as well as compliance. For instance, image analysis software is used to direct and manage a reader via analysis of imaging time points.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global mobile stroke unit market size was valued at USD 35.80 million in 2023 and is projected to grow at a CAGR of 5.2% from 2024 to 2030. Rising incidence of strokes increased focus on early treatment of stroke patients are driving the demand for efficient and timely stroke care services.

• The global brain tumor diagnosis and therapeutics market size was valued at USD 3.11 billion in 2023 and is projected to grow at a CAGR of 7.1% from 2024 to 2030. The growing launches of brain tumor therapeutics products and the rise in cancer awareness for brain tumor medications drive the market over the forecast period.

Clinical Trial Imaging Market Segmentation

Grand View Research has segmented the clinical trial imaging market on the basis of on service, modality, application, end-use and region:

Clinical Trial Imaging Service Outlook (Revenue, USD Million, 2018 - 2030) • Clinical Trial Design and Consultation Services • Reading and Analytical Services • Operational Imaging Services • System and Technology Support Services • Project and Data Management

Clinical Trial Imaging Modality Outlook (Revenue, USD Million, 2018 - 2030) • Computed Tomography • Magnetic Resonance Imaging • X-Ray • Ultrasound • Optical Coherence Tomography (OCT) • Others

Clinical Trial Imaging Application Outlook (Revenue, USD Million, 2018 - 2030) • NASH • CKD • Diabetes • Cardiovascular Diseases • Ophthalmology • Musculoskeletal • Oncology • Gastroenterology • Pediatrics • Others

Clinical Trial Imaging End-use Outlook (Revenue, USD Million, 2018 - 2030) • Biotechnology and Pharmaceutical companies • Medical Devices Manufacturers • Academic and Government Research Institutes • Contract Research Organizations (CROs) • Others

Clinical Trial Imaging Regional Outlook (Revenue, USD Million, 2018 - 2030) • North America o U.S. o Canada • Europe o UK o Germany o France o Italy o Spain o Denmark o Sweden o Norway • Asia Pacific o India o China o Japan o Australia o Thailand o South Korea • Latin America o Brazil o Mexico o Argentina • Middle East & Africa o South Africa o Saudi Arabia o UAE o Kuwait

Order a free sample PDF of the Clinical Trial Imaging Market Intelligence Study, published by Grand View Research.

Key Companies profiled: • IXICO plc • Navitas Life Sciences • Resonance Health • ProScan Imaging • Radiant Sage LLC • Medpace • Biomedical Systems Corp • Cardiovascular Imaging Technologies • Intrinsic Imaging • BioTelemetry

Recent Developments

• In March 2023, Clario launched a cloud-based image viewer specifically for clinical trials. This innovation aims to streamline medical image analysis and improve its accessibility within the clinical research context

• In May 2023, Cleerly has partnered with ProScan Imaging to provide personalized solutions for cardiac health, which involve analyzing and devising treatment strategies for cardiovascular issues. The partnership is expected to leverage Cleerly's AI-powered platform to examine coronary CT angiography (CCTA) images